Literature DB >> 12122047

The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes.

Geraldine J Kress1, Kirk E Dineley, Ian J Reynolds.   

Abstract

Iron is an essential element for cells but may also be an important cytotoxin. However, very little is known about iron transport, redox status, or toxicity specifically inside cells. In this study, we exploited the sensitivity of fura-2 to quenching by ferrous iron (Fe(2+)) to detect intracellular free iron ([Fe(2+)](i)) in neurons, astrocytes, and oligodendrocytes in primary culture. All cell types exposed to Fe(2+) in the presence of the ionophore pyrithione rapidly accumulated Fe(2+) to a similar extent. The heavy-metal chelators bipyridyl and N,N,N',N'-tetrakis(2-pyridalmethyl)ethyl-enediamine rapidly reversed the increase in [Fe(2+)](i), whereas desferrioxamine had little effect. Interestingly, the Fe(2+)-mediated quenching of fura-2 fluorescence was reversed in a concentration-dependent manner by hydrogen peroxide. This was likely caused by the oxidation of Fe(2+) to Fe(3+) inside the cell. Acute exposure of cells to Fe(2+) was only toxic when the metal was applied together with pyrithione, showing that Fe(2+) is only toxic when elevated inside cells. Interestingly, only neurons and oligodendrocytes were injured by this elevation in [Fe(2+)](i), whereas astrocytes were unaffected, although [Fe(2+)](i) was elevated to the same degree in each cell type. These studies provide a novel approach for detecting [Fe(2+)](i) in a manner sensitive to the redox state of the metal. These studies also provide a model system for the study of the toxic consequences of elevated [Fe(2+)](i) in neural cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122047      PMCID: PMC6757914          DOI: 20026601

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors:  He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury.

Authors:  Jin-Yul Lee; Richard F Keep; Yangdong He; Oren Sagher; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

3.  Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia.

Authors:  Glenda M Bishop; Theresa N Dang; Ralf Dringen; Stephen R Robinson
Journal:  Neurotox Res       Date:  2010-04-30       Impact factor: 3.911

4.  The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period.

Authors:  Carlo Aldinucci; Silvia Maria Maiorca; Paola De Rosa; Mitri Palmi; Claudia Sticozzi; Lucia Ciccoli; Silvia Leoncini; Cinzia Signorini; Giuseppe Valacchi; Gian Paolo Pessina
Journal:  Neurochem Res       Date:  2010-07-18       Impact factor: 3.996

5.  Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway.

Authors:  Jing Chen-Roetling; Zhi Li; Mai Chen; Olatilewa O Awe; Raymond F Regan
Journal:  Neuropharmacology       Date:  2009-02-06       Impact factor: 5.250

Review 6.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

7.  Protective effect of vitreous against hemoglobin neurotoxicity.

Authors:  Jing Chen-Roetling; Kathleen A Regan; Raymond F Regan
Journal:  Biochem Biophys Res Commun       Date:  2018-06-06       Impact factor: 3.575

8.  Targeting heme oxygenase after intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Xiangping Lu; Raymond F Regan
Journal:  Ther Targets Neurol Dis       Date:  2015-01-03

9.  Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.

Authors:  Jayalakshmi Caliaperumal; Shannon Wowk; Sarah Jones; Yonglie Ma; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

10.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.